Content
09/05/2024
Boston, MA USA
CytoTronics
completed $13.5 million Seed Round funding. Investors include
LYFE Capital (lead), Anzu Partners, BoxOne Ventures, Draper Associates, Legend Star, RIT Venture Fund.
About
CytoTronics is commercializing technology emerging from the Harvard University labs to bring unique insights to drug discovery. A revolutionary approach to studying cell biology, powered by microchips.
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
